IncA2 PROTEIN OF PNEUMONIA CHLAMYDIA, Inc PROTEIN GROUP OF CHLAMYDIA AND USE METHOD THEREOF

PROBLEM TO BE SOLVED: To obtain an IncA2 protein group, especially an IncA2 protein of pneumonia chlamydia, which enhances apoptosis effect of an anticancer agent, is exceedingly effective for developing a compound for promoting cancerous cytoclasis by an anticancer agent and has twice continuous tr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHIRAI BOKUKUN, AZUMA YOSHINAO, SUGII MANABU
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To obtain an IncA2 protein group, especially an IncA2 protein of pneumonia chlamydia, which enhances apoptosis effect of an anticancer agent, is exceedingly effective for developing a compound for promoting cancerous cytoclasis by an anticancer agent and has twice continuous transmembrane region of Chlamydia being an intracellular parasitic bacterium. SOLUTION: The IncA2 protein and amino acid sequence are localized in mitochondria and are one of inclusion membrane proteins of pneumonia chlamydia. COPYRIGHT: (C)2007,JPO&INPIT